Breathe Well Live Well
|
Nationwide Children's mobile app may help people better self-manage asthma
News-Medical.net Very early on in her life, 3-year-old Karma Taylor found herself frequently in the Emergency Department in the middle of the night as a result of breathing problems. Karma's mom, Joyce Kelso, felt like she was chasing after her daughter's asthma rather … |
View full post on asthma – Google News
|
Asthma: Omron Academy seeks better treatment for patients
Vanguard With over 15 million people suffering from asthma in Nigeria, health professionals and stakeholders under the Omron Academy have disclosed that strict adherence to asthma medications and proper control of the disorder would prevent severe asthma … |
View full post on asthma – Google News
|
Dexamethasone for asthma in the ER: Better compliance, nearly equal effectiveness
Science Daily Adults with asthma who were treated with one-dose dexamethasone in the emergency department had only slightly higher relapse than patients who were treated with a 5-day course of prednisone. "Enhanced compliance and convenience may support the … |
View full post on asthma – Google News
|
Dexamethasone for Asthma in the ER: Better Compliance
Pharmacy Practice News Adults with asthma who were treated with one dose of dexamethasone in the emergency department (ED) had only slightly higher relapse rates than patients who were treated with a five-day course of prednisone (Ann Emerg Med 2016 Apr 26. [Epub ahead … Single Dose of Dexamethasone for Asthma in the ER Non-Inferior to 5-Day Course of Prednisone One-dose of dexamethasone can improve outcomes of asthmatic patients in ER |
View full post on asthma – Google News
EurekAlert (press release) |
Dexamethasone for asthma in the ER: Better compliance, nearly equal effectiveness American College of Emergency …
EurekAlert (press release) WASHINGTON –Adults with asthma who were treated with one-dose dexamethasone in the emergency department had only slightly higher relapse than patients who were treated with a 5-day course of prednisone. "Enhanced compliance and convenience … |
View full post on asthma – Google News
NDTV |
Blocking A Molecule Can Better Treat Asthma
NDTV The allergic immune response, which triggers the symptoms of asthma, is a complex process, which starts with the over-activation of a certain white blood cell, the allergen-specific helper T cells type 2 that plays an important role in the immune system. Blocking a molecule may help better treat asthma |
View full post on asthma – Google News
Odisha Sun Times |
Blocking a molecule can better treat asthma
Odisha Sun Times The allergic immune response, which triggers the symptoms of asthma, is a complex process, which starts with the over-activation of a certain white blood cell, the allergen-specific helper T cells type 2 that plays an important role in the immune system. Blocking a molecule may help better treat asthma |
View full post on asthma – Google News
|
Discovery could lead to better asthma treatment
Science Daily The international study, led by Dr Stephan Caucheteux, from Cardiff University's School of Medicine, believes their work could ultimately help asthma sufferers around the world. Some 5.4m people in the UK are currently receiving treatment for asthma, … |
View full post on asthma – Google News
Medical Xpress |
Discovery could lead to better asthma treatment
Medical Xpress Obstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale Rosen/Wikipedia/CC BY-SA 2.0. Scientists have made a discovery that could lead to … |
View full post on asthma – Google News
Drug Discovery & Development |
Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health
COPD News Today Boehringer Ingelheim Pharmaceuticals and Propeller Health are partnering to use digital health tools and services to help patients with asthma and chronic obstructive pulmonary disease (COPD) to better cope with their condition. Under the terms of the … FDA Approves Supplemental New Drug Application (sNDA) for Boehringer Ingelheim's STIOLTO RESPIMAT for COPD … Boehringer Ingelheim Enters Commercial Partnership with Propeller Health |
View full post on asthma – Google News